24 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 24
Maravai Lifesciences Reports First Quarter 2024 Financial Results
4:09pm
to commercialization.
Awards and Recognitions:
Maravai was recognized in Fast Company’s most innovative companies in biotech list for the Cygnus
8-K
EX-99.1
lvokqrrqmxfe04zy4it
28 Jan 22
Maravai LifeSciences Acquires MyChem, a Leader in Proprietary Ultra-Pure Nucleotides
8:03am
8-K
EX-99.1
g4n4l3f
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
10-Q
5e9smuh7r4fgz92brh85
12 May 21
Quarterly report
4:26pm
DEF 14A
rmpymeew vk9ix8ag
19 Apr 21
Definitive proxy
4:46pm
PRE 14A
ev3e2gy957 lswxabw
9 Apr 21
Preliminary proxy
4:16pm
424B4
hijj304
9 Apr 21
Prospectus supplement with pricing info
4:02pm
DRS
e6wla lrn3l
25 Mar 21
Draft registration statement
12:00am
10-K
wgle4 j4k6cud
22 Mar 21
Annual report
4:22pm
424B4
v1pl3
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
mqlpquf2z mht
29 Oct 20
IPO registration
5:04pm
DRS/A
2puj6mhxfomg3vh911
23 Oct 20
Draft registration statement (amended)
12:00am